Q1 2018 13F Holders as of 3/31/2018
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
51.1M
-
Number of holders
-
116
-
Total 13F shares, excl. options
-
22.4M
-
Shares change
-
+1.09M
-
Total reported value, excl. options
-
$668M
-
Value change
-
+$29.3M
-
Put/Call ratio
-
0.83
-
Number of buys
-
69
-
Number of sells
-
-45
-
Price
-
$29.85
Significant Holders of REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) as of Q1 2018
141 filings reported holding RGNX - REGENXBIO Inc. - Common Stock, par value $0.0001 per share as of Q1 2018.
REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) has 116 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.4M shares
of 51.1M outstanding shares and own 43.75% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.22M shares), Redmile Group, LLC (2.13M shares), FMR LLC (2.01M shares), RTW INVESTMENTS, LP (1.88M shares), JPMORGAN CHASE & CO (1.48M shares), VANGUARD GROUP INC (1.28M shares), STATE STREET CORP (1.21M shares), PERCEPTIVE ADVISORS LLC (881K shares), Partner Fund Management, L.P. (794K shares), and CITADEL ADVISORS LLC (782K shares).
This table shows the top 116 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.